Safety of exemestane in the Intergroup Exemestane Study.
Coombes
R Charles
RC
Bliss
Judith M
JM
Hall
Emma
E
D000730:Androstadienes / Q000009:adverse effects* / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D001862:Bone Resorption / Q000139:chemically induced*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D012107:Research Design; D013997:Time Factors
D000730:Androstadienes; D047072:Aromatase Inhibitors; C056516:exemestane